Key facts
- This page summarizes Eric Lazer's Form 3/A - Amendment filing for Pasithea Therapeutics Corp. (KTTA).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 07 Oct 2021, 16:07.
Key filing fact
Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Additional SEC filing notes
Footnote F1
This Form 3 was originally and incorrectly filed to disclose Eric Lazer as a 10% holder, specifically owning 902,600 shares of Common Stock through Roxy Capital Corporation ("Roxy"). Mr. Lazer is the Director of Roxy and has sole voting and investment control with respect to the shares held by Roxy. As such, Mr. Lazer may be deemed to beneficially own the shares held directly by Roxy. At this time, the 902,600 shares of Common Stock held by Roxy represent less than 10% of the Common Stock. This amended Form 3/A discloses that Mr. Lazer is not a 10% holder.